A detailed history of Eco R1 Capital, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 5,806,871 shares of KURA stock, worth $65 Million. This represents 4.92% of its overall portfolio holdings.

Number of Shares
5,806,871
Previous 5,806,871 -0.0%
Holding current value
$65 Million
Previous $120 Million 5.1%
% of portfolio
4.92%
Previous 4.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$9.62 - $13.99 $8 Million - $11.6 Million
-831,500 Reduced 12.53%
5,806,871 $61.4 Million
Q1 2022

May 16, 2022

BUY
$11.78 - $16.98 $34.3 Million - $49.5 Million
2,913,934 Added 78.24%
6,638,371 $107 Million
Q2 2021

Aug 16, 2021

BUY
$20.85 - $29.88 $663,030 - $950,184
31,800 Added 0.86%
3,724,437 $77.7 Million
Q1 2021

May 17, 2021

BUY
$24.75 - $39.14 $47.5 Million - $75.1 Million
1,919,600 Added 108.27%
3,692,637 $104 Million
Q4 2020

Feb 16, 2021

SELL
$29.0 - $41.62 $82.2 Million - $118 Million
-2,835,492 Reduced 61.53%
1,773,037 $57.9 Million
Q2 2020

Aug 14, 2020

BUY
$7.95 - $18.81 $8.72 Million - $20.6 Million
1,096,839 Added 31.23%
4,608,529 $75.1 Million
Q1 2020

May 15, 2020

SELL
$6.45 - $14.04 $4.71 Million - $10.3 Million
-730,263 Reduced 17.22%
3,511,690 $34.9 Million
Q4 2019

Feb 14, 2020

BUY
$12.97 - $15.94 $2.59 Million - $3.19 Million
200,000 Added 4.95%
4,241,953 $58.3 Million
Q3 2019

Nov 14, 2019

SELL
$14.75 - $20.87 $18.2 Million - $25.8 Million
-1,234,800 Reduced 23.4%
4,041,953 $61.3 Million
Q4 2018

Feb 14, 2019

BUY
$10.6 - $17.49 $14.6 Million - $24 Million
1,373,778 Added 35.2%
5,276,753 $74.1 Million
Q3 2018

Nov 14, 2018

SELL
$16.65 - $21.85 $28,304 - $37,145
-1,700 Reduced 0.04%
3,902,975 $68.3 Million
Q2 2018

Aug 14, 2018

BUY
$14.8 - $18.8 $2.04 Million - $2.59 Million
137,823 Added 3.66%
3,904,675 $71.1 Million
Q3 2017

Nov 14, 2017

BUY
$6.05 - $14.95 $22.8 Million - $56.3 Million
3,766,852
3,766,852 $56.3 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $749M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.